(MENAFN- IMARC Group)
The latest report by IMARC Group, titled“ Implantable Drug Delivery Devices market Report by Product Type (Implantable Drug Eluting Stents, Implantable Contraceptive Drug Delivery Devices, Implantable Intraocular Drug Delivery Devices, Implantable Brachytherapy Seeds Devices, Implantable Drug Delivery Pump Devices), technology (Biodegradable Implants, Non-Biodegradable Implants), Application (Oncology, Cardiovascular, Autoimmune Diseases, Obstetrics and Gynecology, and Others), End User (Hospitals, Ambulatory Surgery Centers, and Others), and Region 2024-2032 “, The global implantable drug delivery devices market size reached US$ 14.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 26.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.81% during 2024-2032.
Implantable drug delivery devices are medical devices designed to deliver controlled and targeted doses of medication directly to specific areas within the body. These devices are implanted under the skin or within body tissues and are used to administer therapeutic agents over an extended period. Implantable drug delivery devices offer several advantages over traditional methods of drug administration, such as oral pills or injections. The primary benefit of implantable drug delivery devices is their ability to provide sustained and consistent drug release, eliminating the need for frequent dosing. This controlled release mechanism enhances the therapeutic effect of the medication while reducing the risk of side effects associated with sudden drug fluctuations in the bloodstream. Moreover, implantable drug delivery devices can target specific tissues or organs, which is particularly beneficial in treating localized conditions or diseases. By delivering medication directly to the site of action, implantable drug delivery devices can improve treatment outcomes and reduce systemic exposure to the drug. They are widely used for long-term treatment of chronic conditions, as well as for short-term therapies that require precise drug administration. As a result, implantable drug delivery devices find extensive applications in various medical fields, including oncology, pain management, diabetes, and contraception across the globe.
For an in-depth analysis, you can refer sample copy of the report:
https://www.imarcgroup.com/implantable-drug-delivery-devices-market/requestsample
Implantable Drug Delivery Devices Market
Trends and Drivers:
The global implantable drug delivery devices market is primarily driven by the escalating demand for more effective and convenient drug delivery solutions due to the increasing prevalence of chronic diseases, such as cancer, cardiovascular disorders, and diabetes. Implantable drug delivery devices offer targeted and sustained drug release, optimizing therapeutic outcomes and patient compliance for long-term treatments. Moreover, the expanding geriatric population that is more prone to developing such chronic illnesses is positively influencing the market growth as they seek advanced drug delivery methods for better disease management. Apart from this, numerous technological advancements in biocompatible materials, miniaturization, and sensor integration that improve the design and performance of implantable devices, have accelerated the product adoption rate in the medical field. Additionally, the rising demand for minimally invasive (MI) procedures and the rising patient preference for less frequent dosing regimens have augmented the demand for implantable drug delivery devices. Furthermore, increasing investments in research and development (R&D) activities by pharmaceutical companies and medical device manufacturers to launch innovative and customized drug delivery solutions are contributing to market growth. Other factors, including the heightening awareness about the benefits of implantable drug delivery devices, the availability of favorable reimbursement policies, and enhancing focus on personalized medicine, are also anticipated to drive the market further.
Report Segmentation:
The report has segmented the market into the following categories:
Product Type Insights:
Implantable Drug Eluting Stents Implantable Contraceptive Drug Delivery Devices Implantable Intraocular Drug Delivery Devices Implantable Brachytherapy Seeds Devices Implantable Drug Delivery Pump Devices
Technology Insights:
Biodegradable Implants Non-Biodegradable Implants
Application Insights:
Oncology Cardiovascular Autoimmune Diseases Obstetrics and Gynecology Others
End User Insights:
Hospitals Ambulatory Surgery Centers Others
Market Breakup by Region:
North America (United States, Canada) Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others) Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others) Latin America (Brazil, Mexico, Others) Middle East and Africa
Competitive Landscape with Key Player:
Abbott Laboratories Boston Scientific Corporation Delpor Inc. Koninklijke DSM N.V. Medtronic plc Theragenics Corporation
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
MENAFN09022024004122016232ID1107831403
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.